负压伤口疗法对糖尿病足轻、中度缺血创面肉芽组织转化生长因子-β1表达的影响

doi:10.3877/cma.j.issn.1673-9450.2019.01.005

中华损伤与修复杂志(电子版) ›› 2019, Vol. 14 ›› Issue (01) : 20 -25. doi: 10.3877/cma.j.issn.1673-9450.2019.01.005

所属专题：文献；

论著

负压伤口疗法对糖尿病足轻、中度缺血创面肉芽组织转化生长因子-β1表达的影响

孙蕾蕾¹, 朱旅云², 杨少玲²^,^†(

)

^1. 250000　济南，武警山东总队医院内分泌科
^2. 050028　石家庄，解放军白求恩国际和平医院内分泌科

收稿日期:2018-12-18 出版日期:2019-02-01
通信作者: 杨少玲
基金资助:
河北省科技支撑计划项目(12277725)

Effect of negative pressure wound therapy on the expression of transforming growth factor-beta1 in granulation tissue with mild and moderate ischemia wound of diabetic foot

Leilei Sun¹, Lyuyun Zhu², Shaoling Yang²^,^†()

^1. Department of Endocrinology, Shandong Armed Police Hospital, Jinan 250000, China
^2. Department of Endocrinology, Bethune International Peace Hospital of People′s Liberation Army, Shijiazhuang 050028, China

Received:2018-12-18 Published:2019-02-01
Corresponding author: Shaoling Yang
About author:
Corresponding author: Yang Shaoling, Email: yshling@126.com

全文 ( ) 下载PDF ( ) 导出引用

引用本文：

孙蕾蕾, 朱旅云, 杨少玲. 负压伤口疗法对糖尿病足轻、中度缺血创面肉芽组织转化生长因子-β1表达的影响[J/OL]. 中华损伤与修复杂志(电子版), 2019, 14(01): 20-25.

Leilei Sun, Lyuyun Zhu, Shaoling Yang. Effect of negative pressure wound therapy on the expression of transforming growth factor-beta1 in granulation tissue with mild and moderate ischemia wound of diabetic foot[J/OL]. Chinese Journal of Injury Repair and Wound Healing(Electronic Edition), 2019, 14(01): 20-25.

目的

探讨负压伤口疗法(NPWT)对糖尿病足轻、中度缺血创面肉芽组织转化生长因子-β1(TGF-β1)表达的影响。

方法

选取2014年1月至2018年2月在解放军白求恩国际和平医院接受NPWT治疗的43例糖尿病足患者，据踝肱指数(ABI)分为中度缺血组23例(0.5≤ABI<0.7)和轻度缺血组20例(0.7≤ABI<0.9)。于治疗前及治疗14 d后分别取创面肉芽组织，标本分成3份，1份于4%多聚甲醛溶液中固定，4 ℃保存，标本收齐后行免疫组织化学染色，分析TGF-β1平均光密度；另外2份于液氮中转送至-80 ℃冰箱中保存，其中1份行Western blotting法，分析TGF-β1蛋白表达情况，另1份行Real-time PCR，分析TGF-β1 mRNA表达情况。2组间数据比较采用独立样本t检验。

结果

经免疫组织化学染色分析TGF-β1表达，中度缺血组和轻度缺血组经14 d治疗后TGF-β1平均光密度均高于治疗前，差异有统计学意义(P值均小于0.05)，且相较于中度缺血组变化幅度[(38.71±12.78)%]，轻度缺血组[(63.09±10.96)%]升高幅度显著，差异均有统计学意义(t＝－6.66，P<0.05)；经Western blotting法分析TGF-β1蛋白表达水平，中度缺血组和轻度缺血组经14 d治疗后TGF-β1蛋白表达均高于治疗前，差异均有统计学意义(P值均小于0.05)，且相较于中度缺血组变化幅度[(50.31±25.64)%]，轻度缺血组变化幅度[(85.44±27.78)%]升高幅度显著，差异有统计学意义(t＝－4.31，P<0.05)；经Real-time PCR法分析TGF-β1 mRNA表达水平，中度缺血组和轻度缺血组经14 d治疗后TGF-β1 mRNA表达均高于治疗前，差异均有统计学意义(P值均小于0.05)，且相较于中度缺血组变化幅度[(73.85±41.22)%]，轻度缺血组[(129.78±36.71)%]升高幅度显著，差异有统计学意义(t＝－4.67，P<0.05)。

结论

NPWT能促进糖尿病足轻、中度缺血创面肉芽组织TGF-β1的表达，且对糖尿病足轻度缺血创面肉芽组织TGF-β1表达的促进作用优于糖尿病足中度缺血创面。

关键词: 负压伤口疗法, 糖尿病足, 转化生长因子β1, 踝肱指数

Objective

To explore the expression of the TGF-β1 of diabetic foot wound granulation tissue treated by negative pressure wound therapy(NPWT), which with mild or moderate peripheral artery disease.

Methods

Forty three patients at Bethune International Peace Hospital of People′s Liberation Army with diabetic foot ulcers from January 2014 to February 2018 were enrolled in this study and divided into moderate ischemia group [23 cases, 0.5≤ankle-brachial index (ABI)<0.7] and mild ischemia group (20 cases, 0.7≤ABI<0.9) according to the ABI. Granulation tissue biopsies were taken before and 14 days after treatment, which were all divided into three parts: one part were preserved in 4% paraformaldehyde at 4 ℃ for immunohistochemical staining when all specimens collected; the other two parts were transferred in liquid nitrogen to the laboratory immediately and preserved in refrigerator at -80 ℃ for Western blotting and Real-time PCR respectively. Date were compared with independent sample t test.

Result

Immunohistochemical staining showed that optical density of TGF-β1 after 14 days treatment in both moderate and mild ischemia group were higher than those before treatment, the differences were statistically significant (with P values below 0.05), with the increase in mild ischemia group (63.09±10.96)% more significant than moderate ischemia group[(38.71±12.78)%], the difference was statistically significant (t=-6.66, P<0.05). Western blotting showed those the expression of TGF-β1 protein after 14 days treatment were higher than that before treatment in both moderate and mild ischemia group, the differences were statistically significant (with P values below 0.05), compared with the increase in mild ischemia group (50.31±25.64)%, the degree of change in the mild ischemic group [(85.44±27.78)%] was significant, the difference was statistically significant (t=-4.31, P<0.05). Real-time PCR showed that the expression of TGF-β1 gene after 14 days treatment were higher than those before treatment in both moderate and mild ischemia group, the differences were statistically significant (with P values below 0.05). Compared with the change amplitude of the moderate ischemic groups [(73.85±41.22)%], the increase the mild ischemic group [(129.78±36.71)%] was significant, the difference was statistically significant (t=-4.67, P<0.05).

Conclusion

NPWT can promote the expression of TGF-β1 in granulation tissue of diabetic patients with mild and moderate ischemic wounds, moreover, the promotion of TGF-β1 expression in granulation tissue of diabetic foot with mild ischemic wound is better than that of moderate ischemic wound.

Key words: Negative-pressure wound therapy, Diabetic foot, Transforming growth factor-beta1, Ankle brachial index

表1 2组糖尿病足患者一般资料比较

组别	例数	性别(例)		年龄(岁，±s)	空腹血糖(mmol/L, ±s)	糖化血红蛋白(%, ±s)
组别	例数	男	女	年龄(岁，±s)	空腹血糖(mmol/L, ±s)	糖化血红蛋白(%, ±s)
中度缺血组	23	13	10	58.39±6.56	9.97±3.38	10.00±2.07
轻度缺血组	20	8	12	59.00±6.67	8.29±3.92	10.06±1.91
t/χ²值	?	1.17^b		0.30^a	1.51^a	0.10^a
P值	?	0.28		0.77	0.14	0.92
组别	例数	溃疡时间(d, ±s)	谷丙转氨酶(U/L, ±s)	肌酐(mmol/L, ±s )
中度缺血组	23	56.30±19.51	17.75±7.75	64.13±19.90
轻度缺血组	20	54.65±18.60	16.21±7.86	61.85±20.48
t/χ²值	?	0.36^a	0.87^a	0.37^a
P值	?	0.72	0.39	0.71

表1 2组糖尿病足患者一般资料比较

组别	例数	性别(例)		年龄(岁，±s)	空腹血糖(mmol/L, ±s)	糖化血红蛋白(%, ±s)
组别	例数	男	女	年龄(岁，±s)	空腹血糖(mmol/L, ±s)	糖化血红蛋白(%, ±s)
中度缺血组	23	13	10	58.39±6.56	9.97±3.38	10.00±2.07
轻度缺血组	20	8	12	59.00±6.67	8.29±3.92	10.06±1.91
t/χ²值	?	1.17^b		0.30^a	1.51^a	0.10^a
P值	?	0.28		0.77	0.14	0.92
组别	例数	溃疡时间(d, ±s)	谷丙转氨酶(U/L, ±s)	肌酐(mmol/L, ±s )
中度缺血组	23	56.30±19.51	17.75±7.75	64.13±19.90
轻度缺血组	20	54.65±18.60	16.21±7.86	61.85±20.48
t/χ²值	?	0.36^a	0.87^a	0.37^a
P值	?	0.72	0.39	0.71

图1 2组糖尿病足患者NPWT治疗前后创面肉芽组织TGF-β1免疫组织化学染色情况(×400)。A示中度缺血组治疗前TGF-β1表达情况；B示治疗14 d后，中度缺血组TGF-β1较治疗前表达明显增多；C示轻度缺血组治疗前TGF-β1表达：D示治疗14 d后，轻度缺血组TGF-β1表达明显增多；箭头示TGF-β1免疫组织化学染色阳性区域；NPWT为负压伤口疗法；TGF-β1为转化生长因子-β1

表2 2组糖尿病足患者NPWT治疗前后TGF-β1平均光密度值统计结果(±s)

组别	例数	治疗前	治疗14 d后	治疗前后变化值	变化幅度(%)	t₁值	P₁值
中度缺血组	23	0.24±0.03	0.34±0.03	0.12±0.03	38.71±12.78	－20.26	<0.05
轻度缺血组	20	0.28±0.03	0.45±0.03	0.17±0.02	63.09±10.96	－10.26	<0.05
t₂值	?	－4.25	－11.92	-8.12	-6.66	?	?
P₂值	?	<0.05	<0.05	<0.05	<0.05	?	?

表2 2组糖尿病足患者NPWT治疗前后TGF-β1平均光密度值统计结果(±s)

组别	例数	治疗前	治疗14 d后	治疗前后变化值	变化幅度(%)	t₁值	P₁值
中度缺血组	23	0.24±0.03	0.34±0.03	0.12±0.03	38.71±12.78	－20.26	<0.05
轻度缺血组	20	0.28±0.03	0.45±0.03	0.17±0.02	63.09±10.96	－10.26	<0.05
t₂值	?	－4.25	－11.92	-8.12	-6.66	?	?
P₂值	?	<0.05	<0.05	<0.05	<0.05	?	?

图2 Western blotting法分析2组糖尿病足患者经NPWT治疗前后创面肉芽组织TGF-β1蛋白表达情况

表3 2组糖尿病足患者NPWT治疗前后TGF-β1蛋白表达变化(±s)

组别	例数	治疗前	治疗14 d后	治疗前后变化值	变化幅度(%)	t₁值	P₁值
中度缺血组	23	0.07±0.02	0.11±0.02	0.03±0.02	50.31±25.64	－5.56	<0.05
轻度缺血组	20	0.10±0.03	0.19±0.04	0.09±0.03	85.44±27.78	－7.86	<0.05
t₂值	?	－4.70	－7.89	－7.44	－4.31	?	?
P₂值	?	<0.05	<0.05	<0.05	<0.05	?	?

表3 2组糖尿病足患者NPWT治疗前后TGF-β1蛋白表达变化(±s)

组别	例数	治疗前	治疗14 d后	治疗前后变化值	变化幅度(%)	t₁值	P₁值
中度缺血组	23	0.07±0.02	0.11±0.02	0.03±0.02	50.31±25.64	－5.56	<0.05
轻度缺血组	20	0.10±0.03	0.19±0.04	0.09±0.03	85.44±27.78	－7.86	<0.05
t₂值	?	－4.70	－7.89	－7.44	－4.31	?	?
P₂值	?	<0.05	<0.05	<0.05	<0.05	?	?

表4 2组糖尿病足患者NPWT治疗前后TGF-β1 mRNA表达情况(±s)

组别	例数	治疗前	治疗14 d后	治疗前后变化值	变化幅度(%)	t₁值	P₁值
中度缺血组	23	1.04±0.19	1.77±0.38	0.73±0.37	73.85±41.22	－8.32	<0.05
轻度缺血组	20	1.26±0.16	2.85±0.38	1.59±0.38	129.78±36.71	－17.28	<0.05
t₂值	?	－4.03	－9.32	－7.55	－4.67	?	?
P₂值	?	<0.05	<0.05	<0.05	<0.05	?	?

表4 2组糖尿病足患者NPWT治疗前后TGF-β1 mRNA表达情况(±s)

组别	例数	治疗前	治疗14 d后	治疗前后变化值	变化幅度(%)	t₁值	P₁值
中度缺血组	23	1.04±0.19	1.77±0.38	0.73±0.37	73.85±41.22	－8.32	<0.05
轻度缺血组	20	1.26±0.16	2.85±0.38	1.59±0.38	129.78±36.71	－17.28	<0.05
t₂值	?	－4.03	－9.32	－7.55	－4.67	?	?
P₂值	?	<0.05	<0.05	<0.05	<0.05	?	?

[1]	Wang L, Gao P, Zhang M, et al. Prevalence and Ethnic Pattern of Diabetes and Prediabetes in China in 2013[J]. JAMA, 2017, 317(24): 2515-2523.
[2]	Wang A, Xu Z, Mu Y, et al. Clinical characteristics and medical costs in patients with diabetic amputation and nondiabetic patients with nonacute amputation in central urban hospitals in China[J]. Int J Low Extrem Wounds, 2014, 13(1): 17-21.
[3]	Schintler MV. Negative pressure therapy: theory and practice[J]. Diabetes Metab Res Rev, 2012, 28 Suppl 1: 72-77.
[4]	Yang SL, Zhu LY, Han R, et al. Effect of Negative Pressure Wound Therapy on Cellular Fibronectin and Transforming Growth Factor-β1 Expression in Diabetic Foot Wounds[J]. Foot Ankle Int, 2017, 38(8): 893-900.
[5]	陈嘉伦. 临床内分泌学[M]. 上海：上海科学技术出版社, 2011: 1142.
[6]	Norgren L, Hiatt WR, Dormandy JA, et al. Inter-society consensus for the management of peripheral arterial disease[J]. Int Angiol, 2007, 26(2): 81-157.
[7]	Volmer-Thole M, Lobmann R. Neuropathy and Diabetic Foot Syndrome[J]. Int J Mol Sci, 2016, 17(6).
[8]	Falanga V. Wound healing and its impairment in the diabetic foot[J]. Lancet, 2005, 366(9498): 1736-1743.
[9]	Peplow PV, Baxter GD. Gene expression and release of growth factors during delayed wound healing: a review of studies in diabetic animals and possible combined laser phototherapy and growth factor treatment to enhance healing[J]. Photomed Laser Surg, 2012, 30(11): 617-636.
[10]	Rafehi H, El-Osta A, Karagiannis TC. Epigenetic mechanisms in the pathogenesis of diabetic foot ulcers[J]. J Diabetes Complications, 2012, 26(6): 554-561.
[11]	Brownrigg JR, Griffin M, Hughes CO, et al. Influence of foot ulceration on cause-specific mortality in patients with diabetes mellitus[J]. J Vasc Surg, 2014, 60(4): 982-986. e3.
[12]	Brownrigg JR, Davey J, Holt PJ, et al. The association of ulceration of the foot with cardiovascular and all-cause mortality in patients with diabetes: a meta-analysis[J]. Diabetologia, 2012, 55(11): 2906-2912.
[13]	Nain PS, Uppal SK, Garg R, et al. Role of negative pressure wound therapy in healing of diabetic foot ulcers[J]. J Surg Tech Case Rep, 2011, 3(1): 17-22.
[14]	Dumville JC, Hinchliffe RJ, Cullum N, et al. Negative pressure wound therapy for treating foot wounds in people with diabetes mellitus[J]. Cochrane Database Syst Rev, 2013(10): CD010318.
[15]	Blume PA, Walters J, Payne W, et al. Comparison of negative pressure wound therapy using vacuum-assisted closure with advanced moist wound therapy in the treatment of diabetic foot ulcers: a multicenter randomized controlled trial[J]. Diabetes Care, 2008, 31(4): 631-636.
[16]	Al-Mulla F, Leibovich SJ, Francis IM, et al. Impaired TGF-β signaling and a defect in resolution of inflammation contribute to delayed wound healing in a female rat model of type 2 diabetes[J]. Mol Biosyst, 2011, 7(11): 3006-3020.
[17]	Gasca-Lozano LE, Lucano-Landeros S, Ruiz-Mercado H, et al. Pirfenidone Accelerates Wound Healing in Chronic Diabetic Foot Ulcers: A Randomized, Double-Blind Controlled Trial[J]. J Diabetes Res, 2017: 3159798.
[18]	Jude EB, Blakytny R, Bulmer J, et al. Transforming growth factor-beta 1, 2, 3 and receptor type I and II in diabetic foot ulcers[J]. Diabet Med, 2002, 19(6): 440-447.
[19]	Zhang F, Ren Y, Liu P, et al. Expression of TGF-β1 and miRNA-145 in patients with diabetic foot ulcers[J]. Exp Ther Med, 2016, 11(5): 2011-2014.
[20]	Demidova-Rice TN, Hamblin MR, Herman IM. Acute and impaired wound healing: pathophysiology and current methods for drug delivery, part 2: role of growth factors in normal and pathological wound healing: therapeutic potential and methods of delivery[J]. Adv Skin Wound Care, 2012, 25(8): 349-370.
[21]	Margadant C, Sonnenberg A. Integrin-TGF-beta crosstalk in fibrosis, cancer and wound healing[J]. EMBO Rep, 2010, 11(2): 97-105.
[22]	Penn JW, Grobbelaar AO, Rolfe KJ. The role of the TGF-β family in wound healing, burns and scarring: a review[J]. Int J Burns Trauma, 2012, 2(1): 18-28.
[23]	Kilpadi DV, Bower CE, Reade CC, et al. Effect of Vacuum Assisted Closure Therapy on early systemic cytokine levels in a swine model[J]. Wound Repair Regen, 2006, 14(2): 210-215.
[24]	McNulty AK, Schmidt M, Feeley T, et al. Effects of negative pressure wound therapy on cellular energetics in fibroblasts grown in a provisional wound (fibrin) matrix[J]. Wound Repair Regen, 2009, 17(2): 192-199.
[25]	王志勇. 封闭负压引流技术对创面组织中PDGF及TGF-β表达的影响[D]．苏州：苏州大学， 2011.

[1]	王杰, 袁泉, 王玥琦, 乔佳君, 谭春丽, 夏仲元, 刘守尧. 溃疡油在糖尿病足溃疡治疗中的应用效果及安全性观察[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(06): 480-484.
[2]	姜珊, 李湘燕, 田硕涵, 温冰, 何睿, 齐心. 采用优化抗感染治疗模式改善糖尿病足感染预后的临床观察[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(05): 398-403.
[3]	别瑶, 曹志斌, 辛静, 王健楠, 惠宗光. 应用基质血管成分细胞治疗糖尿病足溃疡的研究进展[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(05): 453-456.
[4]	谢芬, 陈洁, 张媛媛, 刘茜, 胡芬, 李恭驰, 李炳辉, 金环. 移动健康管理模式在糖尿病足管理中的应用效果观察[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(04): 335-340.
[5]	苏永涛, 王春雷, 徐广琪, 关中正, 焦伟, 隋颖. 胫骨骨膜牵张术联合富血小板血浆对治疗糖尿病足溃疡的疗效观察[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(03): 238-244.
[6]	杨丽, 李文颖, 田园, 周林熙, 王伟. 脂质水胶体硫酸银敷料和蔗糖八硫酸盐敷料在糖尿病足溃疡中的应用进展[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(03): 271-275.
[7]	廖晓霜, 曾李, 杨波. 脱细胞同种异体真皮联合自体皮修复糖尿病足创面的临床效果[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(01): 46-50.
[8]	孙艺玮, 陈炜, 秦巍, 杜景辰, 孟昕, 周永军. 血管腔内介入治疗糖尿病足合并下肢动脉硬化闭塞症患者术后再狭窄与血清炎症因子的相关性[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(01): 34-40.
[9]	张健, 刘小龙, 查天建, 姚俊杰, 王傑. 富含血小板血浆联合异种脱细胞真皮基质修复糖尿病足缺血性创面的临床效果[J/OL]. 中华损伤与修复杂志(电子版), 2023, 18(06): 503-506.
[10]	赵雅玫, 谢斌, 陈艳, 吴健. 抗生素骨水泥联合负压封闭引流对糖尿病足溃疡临床疗效的荟萃分析[J/OL]. 中华损伤与修复杂志(电子版), 2023, 18(05): 427-433.
[11]	鲍亚慧, 曹志斌, 王健楠, 别瑶, 孙晓东, 惠宗光. 应用羧甲基纤维素钠银敷料联合封闭负压吸引治疗糖尿病足溃疡的疗效[J/OL]. 中华损伤与修复杂志(电子版), 2023, 18(04): 326-330.
[12]	雷霞, 李炳辉, 王晓蓉, 张丽娟, 刘慧真, 王卉, 李恭驰. 对糖尿病足溃疡诱因与发生部位的临床观察[J/OL]. 中华损伤与修复杂志(电子版), 2023, 18(02): 104-108.
[13]	赛甫丁·艾比布拉, 买买提·依斯热依力, 李义亮, 王永康, 王志, 克力木·阿不都热依木. 不同材质补片修补对腹壁疝大鼠腹横筋膜组织转化生长因子-β1及Collagen合成代谢的作用[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(02): 161-167.
[14]	赵峰, 邓默. 纤维蛋白原水平、踝肱指数与外周血管支架治疗下肢动脉硬化闭塞症后再狭窄的关系[J/OL]. 中华临床医师杂志(电子版), 2024, 18(02): 144-151.
[15]	黄晨, 庄炜钊, 刘合祝, 李永生, 王倩, 唐郁宽. 富血小板凝胶联合腔内血管成形术治疗缺血性糖尿病足的研究[J/OL]. 中华介入放射学电子杂志, 2024, 12(01): 27-32.

阅读次数

全文

摘要

选择文件类型/文献管理软件名称

选择包含的内容

Effect of negative pressure wound therapy on the expression of transforming growth factor-beta1 in granulation tissue with mild and moderate ischemia wound of diabetic foot

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

Effect of negative pressure wound therapy on the expression of transforming growth factor-beta1 in granulation tissue with mild and moderate ischemia wound of diabetic foot